Nicotine Polacrilex Lozenge
Product Images NDC 72162-2287

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 72162-2287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (721622287extendedlabel)

A text panel providing usage guidance for Nicotine Polacrilex 2 mg lozenges. It includes age restrictions, a recommendation to read the User's Guide, and instructions on lozenge use tailored by the timing of the first cigarette after waking. The panel also contains a 12-week dosage schedule in a table, specifying lozenge frequency for weeks 1 to 12 in three periods.*

FDA Label Image

Wallet Card Image 1 (Image 01)

An illustrated wallet card with the heading 'My most important reasons to quit smoking are:' followed by six blank lines for personal notes or reasons. The card is framed by a gray border, designed to be kept as a motivational reminder.*

FDA Label Image

Wallet Card Image 2 (Image 02)

A wallet card illustration providing contact phone numbers for help quitting smoking. It includes the American Lung Association, American Cancer Society, and American Heart Association helplines, along with a note encouraging finding a quitting buddy or friend who has quit.*

FDA Label Image

Smoke Free Habits Logo (Image 03)

FDA Label Image

Upc Example (Image 04)

FDA Label Image

Reminder Stickers (Image 05)

An instructional diagram showing a four-step reminder system for nicotine lozenge usage on a calendar. It highlights step 1 (1 lozenge every 1 to 2 hours at week 1), step 2 (1 lozenge every 2 to 4 hours at week 7), step 3 (1 lozenge every 4 to 8 hours at week 10), and ex-smoker status at 12 weeks after quit date.*

FDA Label Image

Label (Lbl721622287)

Drug Facts label for Nicotine Polacrilex 2 mg lozenge includes active ingredient, purpose, uses, warnings, other information, directions, and inactive ingredients. The label highlights the active ingredient nicotine polacrilex, intended to help stop smoking by reducing withdrawal symptoms and craving. It provides detailed warnings and directions for proper use, storage instructions, and lists inactive ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.